Monitoring Postoperative Crohn’s Disease—Closing the Gap
Crossref DOI link: https://doi.org/10.1007/s10620-023-08051-8
Published Online: 2023-08-07
Published Print: 2023-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Fudman, David I.
Text and Data Mining valid from 2023-08-07
Version of Record valid from 2023-08-07
Article History
Accepted: 13 July 2023
First Online: 7 August 2023
Declarations
:
: DF reports consulting/advisory board fees from Pfizer, Fresenius Kabi.
Free to read: This content has been made available to all.